Knotnerus Tim Jasper Insider Trades & Stock Holdings

Chief Executive Officer · AgomAb Therapeutics NV · Latest filing Oct 6, 2026

Knotnerus Tim Jasper, Chief Executive Officer at AgomAb Therapeutics NV has 2 Form 4 trades on file since Oct 5, 2026. Open-market activity: 2 purchases ($94.38K) and 0 sales ($0), net +$94.38K. Latest filing: acquired 5K shares of $AGMB on Oct 6, 2026 at $8.70.

Trades on file

2

Open-market bought

$94.38K

Open-market sold

$0

Net open-market

+$94.38K

Latest filing

Oct 6, 2026

All insider trades by Knotnerus Tim Jasper

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 6, 2026	$AGMB	Buy (Open-market buy)	5K	$8.70	$43.50K			-0.3%			Chief Executive Officer		—
Oct 5, 2026	$AGMB	Buy (Open-market buy)	6K	$8.48	$50.88K			+4.6%			Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Knotnerus Tim Jasper traded

• $AGMB

Frequently asked questions

Has Knotnerus Tim Jasper been buying or selling stock?

Knotnerus Tim Jasper has 2 open-market purchases and 0 open-market sales on file, net +$94.38K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Knotnerus Tim Jasper's latest insider trade?

acquired 5K shares of $AGMB on Oct 6, 2026 at $8.70.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.